Sun-Woo Hong
Amministratore Delegato presso mCureX Therapeutics, Inc.
Patrimonio netto: 706 890 $ in data 30/04/2024
Profilo
Sun-Woo Hong is currently the Chief Executive Officer at mCureX Therapeutics, Inc. Prior to this, he worked as the Director, Senior Managing Director & Head-Research at OliX Pharmaceuticals, Inc. Dr. Hong completed his undergraduate and doctorate degrees from Pohang University of Science & Technology and his graduate degree from Korea University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/03/2024 | 62 348 ( 0.38% ) | 706 890 $ | 30/04/2024 |
Posizioni attive di Sun-Woo Hong
| Società | Posizione | Inizio |
|---|---|---|
mCureX Therapeutics, Inc.
 mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Amministratore Delegato | 01/01/2021 |
Precedenti posizioni note di Sun-Woo Hong
| Società | Posizione | Fine |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Direttore/Membro del Consiglio | - |
Formazione di Sun-Woo Hong
| Pohang University of Science & Technology | Doctorate Degree |
| Korea University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OLIX PHARMACEUTICALS, INC | Health Technology |
| Aziende private | 1 |
|---|---|
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Health Technology |
- Borsa valori
- Insiders
- Sun-Woo Hong
